Scarica l'app Stockscreener
3.94
1.75%
-0.07
Precedente Chiudi:
$4.01
Aprire:
$4.0014
Volume 24 ore:
1,014
Relative Volume:
0.06
Capitalizzazione di mercato:
$143.04M
Reddito:
-
Utile/perdita netta:
$-25.50M
Rapporto P/E:
-5.1169
EPS:
-0.77
Flusso di cassa netto:
$-30.10M
1 W Prestazione:
+0.25%
1M Prestazione:
+34.70%
6M Prestazione:
+26.75%
1 anno Prestazione:
+37.72%
Intervallo 1D:
$4.00
$4.06
Intervallo di 1 settimana:
$3.86
$4.4299
Portata 52W:
$2.20
$4.48
Eupraxia Pharmaceuticals Inc Stock (EPRX) Company Profile
Nome
Eupraxia Pharmaceuticals Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta EPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPRX
Eupraxia Pharmaceuticals Inc
|
4.00 | 143.04M | 0 | -25.50M | -30.10M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.98 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.91 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
638.88 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.02 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
252.76 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Eupraxia Pharmaceuticals Inc Stock (EPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-21 | Iniziato | Craig Hallum | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
Eupraxia Pharmaceuticals Inc Borsa (EPRX) Ultime notizie
(EPRX.WT.A) Strategic Equity Report - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Inc. - MENAFN.com
Stocks In Play: Eupraxia Pharmaceuticals Inc. By Baystreet.ca - Investing.com Canada
Aptose Biosciences Inc. - Baystreet.ca
Eupraxia Pharma Reports Positive 9-month Data From RESOLVE Phase 1b/2a Study - Nasdaq
Eupraxia Pharmaceuticals Reports Positive Nine-Month Outcomes in EoE Trial - TipRanks
When the Price of (EPRX) Talks, People Listen (EPRX:CA) - news.stocktradersdaily.com
Breakthrough: New EoE Drug Shows Unprecedented 9-Month DurationCould Transform Treatment Landscape - Stock Titan
(EPRX) Advanced Equity Analysis (EPRX:CA) - news.stocktradersdaily.com
(EPRX.WT.A) Proactive Strategies (EPRX.WT.A:CA) - news.stocktradersdaily.com
(EPRX.WT.A) Dynamic Trading Report - news.stocktradersdaily.com
How the (EPRX) price action is used to our Advantage (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals to Showcase Clinical Advances at April and May Conferences - MSN
Eupraxia Pharmaceuticals to Present at Investor and Scientific Conferences in April and May - The Manila Times
Eupraxia Pharmaceuticals Inc. to Present at Multiple Upcoming Investor and Scientific Conferences in April and May 2025 - Nasdaq
(EPRX) Trading Signals (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Unveils Breakthrough Osteoarthritis and EoE Treatment Data Across Global Medical Forums - Stock Titan
(EPRX.WT.A) Optimized Trading Opportunities - news.stocktradersdaily.com
(EPRX) Optimized Trading Opportunities (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results - ADVFN
Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 - ADVFN
Eupraxia Pharmaceuticals Announces Positive Data from RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis - ADVFN
(EPRX.WT.A) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, 'Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed', on November 15, 2024 - ADVFN
(EPRX) Investment Performance Report (EPRX:CA) - news.stocktradersdaily.com
TSX Penny Stock Highlights Calfrac Well Services And Two More Compelling Picks - simplywall.st
Closing Bell: Eupraxia Pharmaceuticals Inc WT up on Wednesday (EPRX-WT) - The Globe and Mail
Long Term Trading Analysis for (EPRX.WT.A) - news.stocktradersdaily.com
(EPRX) Technical Pivots with Risk Controls (EPRX:CA) - news.stocktradersdaily.com
When (EPRX.WT.A) Moves Investors should Listen - news.stocktradersdaily.com
Raymond James Financial Inc. Makes New $37,000 Investment in Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) - Defense World
(EPRX) Proactive Strategies (EPRX:CA) - news.stocktradersdaily.com
(EPRX.WT.A) Investment Analysis and Advice - news.stocktradersdaily.com
(EPRX) Equity Trading Insights (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (OTCMKTS:EPRXF) Stock Price Down 1% – Should You Sell? - Defense World
(EPRX) On The My Stocks Page (EPRX:CA) - news.stocktradersdaily.com
(EPRX) Strategic Investment Report (EPRX:CA) - news.stocktradersdaily.com
(EPRX) Stock Market Analysis (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (EPRX) Projected to Post Earnings on Monday - Defense World
When (EPRX) Moves Investors should Listen (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals Reports Strong Q4 2024 Results and Operational Progress - MSN
Here's Why We're Watching Eupraxia Pharmaceuticals' (TSE:EPRX) Cash Burn Situation - Yahoo
Learn to Evaluate (EPRX) using the Charts (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals files report with SEC By Investing.com - Investing.com South Africa
Eupraxia Pharmaceuticals files report with SEC - Investing.com India
Eupraxia Pharmaceuticals Reports Fourth Quarter 2024 Financial Results -March 20, 2025 at 05:38 pm EDT - MarketScreener
(EPRX) Equity Market Report (EPRX:CA) - news.stocktradersdaily.com
Eupraxia Pharmaceuticals (NASDAQ:EPRX) Trading Down 1.7% – What’s Next? - The AM Reporter
How to Take Advantage of moves in (EPRX) (EPRX:CA) - Stock Traders Daily
(EPRX) Daily Stock Insights (EPRX:CA) - Stock Traders Daily
(EPRX) Stock Evaluation Report (EPRX:CA) - Stock Traders Daily
Eupraxia Pharmaceuticals Inc Azioni (EPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):